Lee's Pharmaceutical Holdings Limited
LPCUF
$0.185
-$0.0091-4.69%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 5,193.82% | 5,191.37% | 288.72% | 288.49% | -- |
| Total Depreciation and Amortization | -4.00% | -4.18% | -9.13% | -9.19% | -- |
| Total Amortization of Deferred Charges | 17.16% | 16.94% | -- | -- | -- |
| Total Other Non-Cash Items | 64.61% | 64.30% | -35.32% | -35.24% | -- |
| Change in Net Operating Assets | 34.57% | 34.69% | -- | -- | -- |
| Cash from Operations | 159.04% | 158.56% | 51.39% | 51.30% | -- |
| Capital Expenditure | -119.54% | -119.14% | 20.74% | 20.78% | -- |
| Sale of Property, Plant, and Equipment | 112.33% | 112.33% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -122.79% | -122.37% | 27.26% | 27.31% | -- |
| Cash from Investing | -121.90% | -121.48% | 26.19% | 26.23% | -- |
| Total Debt Issued | 76.09% | 76.09% | -- | -- | -- |
| Total Debt Repaid | -109.19% | -109.19% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -151.29% | -150.83% | -0.29% | -0.24% | -- |
| Other Financing Activities | -27.25% | -27.25% | 27.25% | 27.25% | -- |
| Cash from Financing | -312.30% | -311.53% | 35.36% | 35.28% | -- |
| Foreign Exchange rate Adjustments | -86.94% | -86.48% | 50.00% | 50.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 335.73% | 334.92% | 183.98% | 183.93% | -- |